Ocular manifestations and treatment safety in hepatitis C patients undergoing direct-acting antiviral therapy: a prospective cohort study

ABSTRACT Objective: To report the frequency of ocular manifestations in patients undergoing direct-acting antiviral therapy and assess treatment safety based on outcomes; to identify demographic variables associated with hepatitis C virus infection; evaluate treatment effectiveness through sustaine...

Full description

Saved in:
Bibliographic Details
Main Authors: Guilherme Thomé de Carvalho, Carlos Eduardo Brandão Mello, Kelma Macedo Pohlmann Simões, Mário Martins dos Santos Motta, Max Kopti Fakoury, Bruno Vasconcelos Coimbra, Laura Gomes Nunes Melo, Flávio Mac Cord Medina
Format: Article
Language:English
Published: Sociedade Brasileira de Oftalmologia 2025-02-01
Series:Revista Brasileira de Oftalmologia
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0034-72802025000100203&lng=en&tlng=en
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823859098696810496
author Guilherme Thomé de Carvalho
Carlos Eduardo Brandão Mello
Kelma Macedo Pohlmann Simões
Mário Martins dos Santos Motta
Max Kopti Fakoury
Bruno Vasconcelos Coimbra
Laura Gomes Nunes Melo
Flávio Mac Cord Medina
author_facet Guilherme Thomé de Carvalho
Carlos Eduardo Brandão Mello
Kelma Macedo Pohlmann Simões
Mário Martins dos Santos Motta
Max Kopti Fakoury
Bruno Vasconcelos Coimbra
Laura Gomes Nunes Melo
Flávio Mac Cord Medina
author_sort Guilherme Thomé de Carvalho
collection DOAJ
description ABSTRACT Objective: To report the frequency of ocular manifestations in patients undergoing direct-acting antiviral therapy and assess treatment safety based on outcomes; to identify demographic variables associated with hepatitis C virus infection; evaluate treatment effectiveness through sustained virological response. Methods: A prospective cohort study was conducted involving chronic hepatitis C patients undergoing direct-acting antiviral therapy. Ophthalmological evaluations were conducted before treatment initiation and upon completion. Patients were advised to return in case of any visual symptoms. Results: The study comprised 30 patients, predominantly treated with sofosbuvir + velpatasvir. All patients achieved sustained virological response, and a notable improvement in fibrosis degree post-treatment was observed. No ocular complications attributable to direct-acting antiviral therapy were reported during the study. Conclusion: This study underscores the safety profile of direct-acting antiviral therapy concerning ocular manifestations. Demographic trends align with existing literature, and all patients achieved sustained virological response alongside improved liver fibrosis. These findings support the efficacy and safety of direct-acting antiviral therapy for hepatitis C patients.
format Article
id doaj-art-485bb12e00624f239636deb7e217904d
institution Kabale University
issn 1982-8551
language English
publishDate 2025-02-01
publisher Sociedade Brasileira de Oftalmologia
record_format Article
series Revista Brasileira de Oftalmologia
spelling doaj-art-485bb12e00624f239636deb7e217904d2025-02-11T07:43:54ZengSociedade Brasileira de OftalmologiaRevista Brasileira de Oftalmologia1982-85512025-02-018410.37039/1982.8551.2025.0006Ocular manifestations and treatment safety in hepatitis C patients undergoing direct-acting antiviral therapy: a prospective cohort studyGuilherme Thomé de Carvalhohttps://orcid.org/0000-0003-4801-7007Carlos Eduardo Brandão Mellohttps://orcid.org/0000-0001-8965-6556Kelma Macedo Pohlmann Simõeshttps://orcid.org/0000-0003-3230-5530Mário Martins dos Santos Mottahttps://orcid.org/0000-0002-1892-6480Max Kopti Fakouryhttps://orcid.org/0000-0002-7003-9942Bruno Vasconcelos Coimbrahttps://orcid.org/0000-0002-2938-7072Laura Gomes Nunes Melohttps://orcid.org/0000-0001-5676-2213Flávio Mac Cord Medinahttps://orcid.org/0000-0003-2656-2960ABSTRACT Objective: To report the frequency of ocular manifestations in patients undergoing direct-acting antiviral therapy and assess treatment safety based on outcomes; to identify demographic variables associated with hepatitis C virus infection; evaluate treatment effectiveness through sustained virological response. Methods: A prospective cohort study was conducted involving chronic hepatitis C patients undergoing direct-acting antiviral therapy. Ophthalmological evaluations were conducted before treatment initiation and upon completion. Patients were advised to return in case of any visual symptoms. Results: The study comprised 30 patients, predominantly treated with sofosbuvir + velpatasvir. All patients achieved sustained virological response, and a notable improvement in fibrosis degree post-treatment was observed. No ocular complications attributable to direct-acting antiviral therapy were reported during the study. Conclusion: This study underscores the safety profile of direct-acting antiviral therapy concerning ocular manifestations. Demographic trends align with existing literature, and all patients achieved sustained virological response alongside improved liver fibrosis. These findings support the efficacy and safety of direct-acting antiviral therapy for hepatitis C patients.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0034-72802025000100203&lng=en&tlng=enManifestações ocularesHepatite CAntiviraisSofosbuvirVelpatasvirResultado do tratamento
spellingShingle Guilherme Thomé de Carvalho
Carlos Eduardo Brandão Mello
Kelma Macedo Pohlmann Simões
Mário Martins dos Santos Motta
Max Kopti Fakoury
Bruno Vasconcelos Coimbra
Laura Gomes Nunes Melo
Flávio Mac Cord Medina
Ocular manifestations and treatment safety in hepatitis C patients undergoing direct-acting antiviral therapy: a prospective cohort study
Revista Brasileira de Oftalmologia
Manifestações oculares
Hepatite C
Antivirais
Sofosbuvir
Velpatasvir
Resultado do tratamento
title Ocular manifestations and treatment safety in hepatitis C patients undergoing direct-acting antiviral therapy: a prospective cohort study
title_full Ocular manifestations and treatment safety in hepatitis C patients undergoing direct-acting antiviral therapy: a prospective cohort study
title_fullStr Ocular manifestations and treatment safety in hepatitis C patients undergoing direct-acting antiviral therapy: a prospective cohort study
title_full_unstemmed Ocular manifestations and treatment safety in hepatitis C patients undergoing direct-acting antiviral therapy: a prospective cohort study
title_short Ocular manifestations and treatment safety in hepatitis C patients undergoing direct-acting antiviral therapy: a prospective cohort study
title_sort ocular manifestations and treatment safety in hepatitis c patients undergoing direct acting antiviral therapy a prospective cohort study
topic Manifestações oculares
Hepatite C
Antivirais
Sofosbuvir
Velpatasvir
Resultado do tratamento
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0034-72802025000100203&lng=en&tlng=en
work_keys_str_mv AT guilhermethomedecarvalho ocularmanifestationsandtreatmentsafetyinhepatitiscpatientsundergoingdirectactingantiviraltherapyaprospectivecohortstudy
AT carloseduardobrandaomello ocularmanifestationsandtreatmentsafetyinhepatitiscpatientsundergoingdirectactingantiviraltherapyaprospectivecohortstudy
AT kelmamacedopohlmannsimoes ocularmanifestationsandtreatmentsafetyinhepatitiscpatientsundergoingdirectactingantiviraltherapyaprospectivecohortstudy
AT mariomartinsdossantosmotta ocularmanifestationsandtreatmentsafetyinhepatitiscpatientsundergoingdirectactingantiviraltherapyaprospectivecohortstudy
AT maxkoptifakoury ocularmanifestationsandtreatmentsafetyinhepatitiscpatientsundergoingdirectactingantiviraltherapyaprospectivecohortstudy
AT brunovasconceloscoimbra ocularmanifestationsandtreatmentsafetyinhepatitiscpatientsundergoingdirectactingantiviraltherapyaprospectivecohortstudy
AT lauragomesnunesmelo ocularmanifestationsandtreatmentsafetyinhepatitiscpatientsundergoingdirectactingantiviraltherapyaprospectivecohortstudy
AT flaviomaccordmedina ocularmanifestationsandtreatmentsafetyinhepatitiscpatientsundergoingdirectactingantiviraltherapyaprospectivecohortstudy